Cervical cancer will be the first human cancer eliminated through coordinated global action. A new special issue of Cancer Biology & Medicine brings together leading experts from around the world to examine progress, challenges, and innovations in prevention, screening, and treatment. From policy frameworks and epidemiological insights to digital health tools and therapeutic vaccines, the collection provides a timely resource for accelerating the World Health Organization’s 2030 targets for cervical cancer elimination and advancing women's health equity worldwide.
Each year, more than 340,000 women die from cervical cancer, with the majority of deaths occurring in low- and middle-income countries. Despite being highly preventable through vaccination and early detection, the disease remains the fourth most common cancer among women. In 2020, the World Health Organization (WHO) launched the Global Strategy to Accelerate the Elimination of Cervical Cancer, setting ambitious “90-70-90” targets for vaccination, screening, and treatment by 2030. Yet vast inequities in health resources, infrastructure, and implementation capacity threaten progress. Addressing these challenges requires not only scientific advances but also strong policy alignment and international cooperation.
To mark the 30th anniversary of the Fourth World Conference on Women and the 2025 World Women's Summit in Beijing, Cancer Biology & Medicine has released a special issue (https://www.cancerbiomed.org/content/22/9) dedicated to eliminating cervical cancer. Guest-edited by Professor Youlin Qiao of the Chinese Academy of Medical Sciences & Peking Union Medical College, the issue highlights global disparities, China's contributions, and the collective scientific and policy innovations needed to accelerate progress. The issue reflects the journal's mission to bridge cutting-edge oncology research with public health priorities, particularly in women's health.
The special issue brings together ten contributions spanning global perspectives, policy analysis, epidemiology, digital innovation, economic evaluation, and novel therapeutics. Highlights include an Editorial from the International Agency for Research on Cancer (IARC/WHO) outlining global disparities and China's contributions; a Perspective exploring how policy modeling can guide resource-sensitive elimination strategies in low- and middle-income countries; and an Original Article analyzing cervical cancer burden and trends in China from 2000 to 2020 in comparison with four Asia-Pacific countries.
Other notable studies showcase technological and clinical advances, such as the first international evaluation of a bilingual digital colposcopy education tool (iDECO), which significantly improves diagnostic accuracy, and the development of a therapeutic multi-epitope protein vaccine targeting HPV16 that demonstrates strong tumor regression in preclinical models.
Beyond these examples, the issue also features research on HPV vaccination willingness, innovative triage algorithms in rural China, intelligent digital platforms for population-based screening, and the economic impact of government-organized programs. Together, these articles provide a comprehensive view of scientific, clinical, and policy innovations driving the global elimination of cervical cancer. The full collection is available online.
“Cervical cancer is the only malignancy we can realistically eliminate through vaccination, screening, and early treatment,” said Professor Youlin Qiao, Guest Editor of the issue. “This special issue demonstrates the collective knowledge and innovation needed to achieve that goal. By combining science, policy, and equity, we can ensure that no woman is left behind in the global drive to eliminate cervical cancer.”
The timing of this issue aligns with renewed global attention to women's health at the 2025 World Women's Summit. By providing evidence-based insights across epidemiology, technology, economics, and therapeutics, Cancer Biology & Medicine aims to inform international collaboration and inspire action. The elimination of cervical cancer is not only a public health objective but also a milestone for gender equity and global health justice.
As the world moves closer to this unprecedented achievement, this special issue offers both a progress report and a call to action: eliminating cervical cancer is possible within our lifetime—but only if the global community works together.
For more details and to access the special issue “Eliminating Cervical Cancer: A Global Health Imperative for Women”, visit Cancer Biology &Medicine online.
Eliminating cervical cancer: a global health imperative for women
DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0529
Progress toward cervical cancer elimination: global disparities and China's contributions
DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0428
Strengthening human papillomavirus vaccination programs through multi-country peer learning: lessons from the CHIC initiative
DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0388
Modeling cervical cancer elimination: a pathway to inform policy decisions
DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0387
Human papillomavirus vaccination willingness under resource inequities: momentary intervention effects of an educational video
DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0400
Cervical cancer burden and trends in China, 2000–2020: Asia-Pacific international comparisons and insights for elimination goals
DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0386
Accelerating the elimination of global cervical cancer through intelligent training for colposcopy
DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0403
Evaluation of the multiple HPV-based “screen and triage” algorithms in real-world settings of rural China
DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0384
Evaluation of an intelligent digital platform for population management in cervical cancer screening
DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0419
Impact of government-organized screening programs on the economic burden of cervical cancer across five disease courses: a multistage regression and mediation analysis
DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0418
A therapeutic multi-epitope protein vaccine targeting HPV16 E6 E7 elicits potent tumor regression and cytotoxic immune responses
DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0370
###
References
Journal
Cancer Biology & Medicine (CBM) is a peer-reviewed open-access journal sponsored by China Anti-cancer Association (CACA) and Tianjin Medical University Cancer Institute & Hospital. The journal monthly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The journal is indexed in SCOPUS, MEDLINE and SCI (IF 8.4, 5-year IF 6.7), with all full texts freely visible to clinicians and researchers all over the world (http://www.ncbi.nlm.nih.gov/pmc/journals/2000/).
END
Toward a cervical cancer–free future: Cancer Biology & Medicine highlights science, policy, and equity
2025-11-20
(Press-News.org)
ELSE PRESS RELEASES FROM THIS DATE:
Population-specific genetic risk scores advance precision medicine for Han Chinese populations
2025-11-20
Researchers at Academia Sinica have developed the first population-specific polygenic risk score (PRS) models for people of Han Chinese ancestry, achieving unprecedented accuracy in predicting risks for common diseases such as diabetes, heart disease, autoimmune disorders. The study, published in Nature on October 15,2025, analyzed genomic and health data from more than half a million Taiwanese participants of the Taiwan Precision Medicine Initiative (TPMI) and demonstrates the transformative potential ...
For young children, finger-counting a stepping stone to higher math skills
2025-11-20
Children who count on their fingers between ages 4 and 6 1/2 have better addition skills by age 7 than those who don’t use their fingers, suggesting that finger counting is an important stepping stone to higher math skills, according to research published by the American Psychological Association.
“Finger counting is not just a tool for immediate success in young children, but a way to support the development of advanced abstract arithmetic skills,” said lead author Catherine Thevenot, PhD, of the University of Lausanne in Switzerland.
Finger counting is widely used by young children as a strategy to solve math problems. However, ...
Mayo Clinic physicians map patients’ brain waves to personalize epilepsy treatment
2025-11-20
ROCHESTER, Minn. — Mayo Clinic researchers have developed a new, personalized approach to deep brain stimulation (DBS) for people with drug-resistant epilepsy. By mapping each patient's unique brain wave patterns, the method allows physicians to target the precise area in the brain where stimulation is most effective, moving beyond the traditional one-size-fits-all approach.
DBS involves implanting electrodes in the brain to deliver electrical pulses that help prevent and control seizures. While effective, DBS is typically administered with electrodes placed in the same brain region across most patients. Mayo Clinic physician-scientists ...
Global Virus Network awards pandemic preparedness grants to advance global surveillance and early detection of viral threats
2025-11-20
Tampa, FL, USA – November 20, 2025 – The Global Virus Network (GVN) is pleased to announce that, for the first time, it is awarding pandemic preparedness research grants, totaling $160,000, to GVN scientists across four continents. These awards support innovative, investigator-led projects designed to enhance viral surveillance, early detection, and scientific preparedness, particularly in regions vulnerable to emerging and re-emerging viral threats.
“These projects represent exactly the kind of targeted, ...
Ginkgo Datapoints launches the Virtual Cell Pharmacology Initiative to build a community-driven data standard for AI drug discovery
2025-11-20
BOSTON — Nov. 20, 2025 — Ginkgo Bioworks (NYSE: DNA) today announced the launch of the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints. This open-source platform is designed to build the first standardized framework for virtual cell modeling in drug discovery by bringing together researchers, pharmaceutical companies and AI developers in a community-driven effort to create the largest public dataset of its kind, aiming to test at least 100,000 compounds and generate >12 billion data points.
Virtual cells, AI-powered digital representations of biological cells, are emerging as a critical ...
Cleveland’s famous sea monster gets a scientific update
2025-11-20
CLEVELAND—About 360 million years ago, the shallow sea above present-day Cleveland was home to a fearsome apex predator: Dunkleosteus terrelli. This 14-foot armored fish ruled the Late Devonian seas with razor-sharp bone blades instead of teeth, making it among the largest and most ferocious arthrodires—an extinct group of shark-like fishes covered in bony armor across their head and torso.
Since its discovery in the 1860s, Dunkleosteus has captivated scientists and the public alike, becoming ...
University of Minnesota chemists pioneer new method for future drug and agrochemical discovery
2025-11-20
MINNEAPOLIS / ST. PAUL (11/20/2025) — A team of organic and computational chemists at the University of Minnesota Twin Cities have created a new, modern tool to make the process of creating pharmaceuticals and agrochemicals faster, cost-effective, and energy-efficient.
The research, recently published in Nature, details a new method for creating the essential starting materials, known as precursors, used in chemical reactions. A patent is pending for this technique.
Chemists use what are called “aryne intermediates” as building blocks to make complex molecules more efficiently in areas such as pharmaceuticals ...
Will my kid be a pro athlete? Study finds what parents think
2025-11-20
COLUMBUS, Ohio – Many children grow up dreaming – or maybe even expecting – that they will become a star in football, basketball or whatever their favorite sport may be.
Most parents have more realistic expectations of their children’s future athletic achievement, a new study finds. But a substantial minority believe their kids will beat the odds and become collegiate, pro or even Olympic athletes.
In a survey of 785 American parents, 34% thought it was somewhat or very likely that their child would become a small-college athlete, 27% thought it was likely they would become a college scholarship athlete, and 17% thought it was somewhat ...
23andMe Research Institute helps reconnect African diaspora to their roots with release of 250+ high-resolution African Genetic Groups
2025-11-20
PALO ALTO, Calif. - November 20, 2025 - For millions of Americans in the African diaspora, genealogical ties and records were severed by the transatlantic slave trade, creating a "brick wall" for those seeking to know their full heritage. Today, 23andMe Research Institute announced a landmark expansion of its genetic ancestry reports and features, unveiling more than 250 high-resolution Genetic Groups across Africa. This significant update provides members with African heritage the most detailed and scientifically ...
Isotope-based method for detecting unknown selenium compounds
2025-11-20
Although present in very small amounts, selenium (Se)-based compounds play important roles in protecting the body from oxidative stress, regulating thyroid hormones, strengthening the immune system, and even detoxifying heavy metals. As we begin to understand more about the biological functions of Se, the need to detect and identify Se-containing compounds has become increasingly important.
Researchers from Chiba University, Japan, have developed a new method that selectively detects Se compounds, addressing a long-standing challenge in the identification of unknown Se-containing compounds. Using a previously unexplored approach, the researchers discovered novel Se-containing molecules in ...